Table 4. Prevalence of adherent-invasive E. coli.
| Characteristics | Number of subjects positive for AIEC (%) | p value | |
|---|---|---|---|
| Disease group | HC (n = 9) | 2 (22.2) | 0.407 |
| CD (n = 18) | 7 (38.9) | ||
| UC (n = 24) | 9 (37.5) | ||
| Disease activity | Active IBD (n = 29) | 11 (37.9) | 0.618 |
| Inactive IBD (n = 13) | 5 (38.5) | ||
| Treatment exposure | Anti-TNF naïve (n = 36) | 14 (38.9) | 0.587 |
| Anti-TNF experienced (n = 6) | 2 (33.3) | ||
| Thiopurine naïve (n = 22) | 9 (40.9) | 0.470 | |
| Thiopurine experienced (n = 20) | 7 (35.0) | ||
AIEC, adherent-invasive E. coli; HC, healthy control; CD, Crohn’s disease; UC, ulcerative colitis; IBD, inflammatory bowel disease